A psychoactive THC-like substance from liverwort, which is consumed as a legal high, also has analgesic and anti-inflammatory effects which might be superior to those of THC from hemp, say scientists in Bern and Zurich.
Certain liverworts, a type of moss, from Japan, New Zealand and Costa Rica contain a substance called perrottetinene that is very similar to the psychoactive substance tetrahydrocannabinol (THC) from cannabis. The liverworts therefore sometimes circulate as legal intoxicants.
A research team led by Jürg Gertsch at the University of Bern and Erick Carreira at the federal technology institute ETH Zurich has now compared perrottetinene and THC biochemically and pharmacologically.
In the journal Science AdvancesExternal link, the researchers report that perrottetinene may be superior to the cannabis drug THC for therapeutic purposes. In low doses, THC is used in various chronic conditions to relieve pain, inflammation, muscle cramps and nausea. However, THC is highly psychoactive in higher doses, so it is considered an illegal drug and is therefore tightly regulated.
Advantages over cannabis
Perrottetinene could prove to be a better alternative for medicine, the scientists believe. Using animal models, they were able to demonstrate that perrottetinene reaches the brain very easily and that, once there, it specifically activates cannabinoid receptors.
“This natural substance has a weaker psychoactive effect and, at the same time, is capable of inhibiting inflammatory processes in the brain,” Carreira said.
In particular, in contrast to THC, perrottetinene inhibits the prostaglandins in the brain which are factors causing inflammation.
However, the researchers emphasise that further studies are needed to better understand the effects and potential side-effects of perrottetinene.
More
More
Cannabis: the comeback of a banned medicine
This content was published on
A multimedia investigation of the potential and limits of one of the most controversial plants of all time.
What can be done to protect biodiversity in your country?
Swiss voters are set to decide on a people’s initiative calling for better protection of ecosystems in the country. Have your say on the September 22 vote.
Switzerland edges closer to stricter screening of foreign investments
This content was published on
Foreign investors are set to face greater scrutiny in Switzerland as one parliamentary chamber passes the so-called Lex China bill.
Increase in animal testing in Switzerland last year
This content was published on
Almost 600,000 animals were used in animal experiments in Switzerland in 2023 - an increase of 1.6% compared to the previous year.
Beleaguered Swiss watch industry calls for political support
This content was published on
The Swiss watch industry is going through difficult times as global demand declines and the strong franc piles on the pressure.
This content was published on
Hollywood star Pamela Anderson will be honoured at the Zurich Film Festival for her career and role in the film The Last Showgirl.
Switzerland to host Ukraine mine action conference in October
This content was published on
Together with Ukraine, Switzerland is organising the Ukraine Mine Action Conference (UMAC2024) in Lausanne on October 17 and 18.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Cannabis products sold in Lidl Switzerland
This content was published on
Hemp containing active ingredient cannabidiol (CBD) can now be bought in Swiss branches of German discount supermarket chain Lidl.
This content was published on
Former interior minister Ruth Dreifuss, nicknamed “dealer of the nation” for introducing ground-breaking drug policies, is one of the figureheads of the country’s legalisation campaign. One of her suggestions is to set up cannabis clubs, a concept her native Geneva is spearheading in Switzerland. Larger cities like Geneva, Bern, Basel and Zurich have created an…
This content was published on
The move, which brings Switzerland in line with other European countries that tolerate dope smoking in small amounts, comes four years after voters rejected a plan to decriminalise cannabis. Following several rounds of discussions in both parliamentary chambers, the House of Representatives agreed to align with the Senate on Thursday, paving the way for the…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.